Jum’ah, H.A.; Otteson, G.E.; Timm, M.M.; Weybright, M.J.; Shi, M.; Horna, P.; Jevremovic, D.; Reichard, K.K.; Olteanu, H.
Measurable Residual Disease Analysis by Flow Cytometry: Assay Validation and Characterization of 385 Consecutive Cases of Acute Myeloid Leukemia. Cancers 2025, 17, 1155.
https://doi.org/10.3390/cancers17071155
AMA Style
Jum’ah HA, Otteson GE, Timm MM, Weybright MJ, Shi M, Horna P, Jevremovic D, Reichard KK, Olteanu H.
Measurable Residual Disease Analysis by Flow Cytometry: Assay Validation and Characterization of 385 Consecutive Cases of Acute Myeloid Leukemia. Cancers. 2025; 17(7):1155.
https://doi.org/10.3390/cancers17071155
Chicago/Turabian Style
Jum’ah, Husam A., Gregory E. Otteson, Michael M. Timm, Matthew J. Weybright, Min Shi, Pedro Horna, Dragan Jevremovic, Kaaren K. Reichard, and Horatiu Olteanu.
2025. "Measurable Residual Disease Analysis by Flow Cytometry: Assay Validation and Characterization of 385 Consecutive Cases of Acute Myeloid Leukemia" Cancers 17, no. 7: 1155.
https://doi.org/10.3390/cancers17071155
APA Style
Jum’ah, H. A., Otteson, G. E., Timm, M. M., Weybright, M. J., Shi, M., Horna, P., Jevremovic, D., Reichard, K. K., & Olteanu, H.
(2025). Measurable Residual Disease Analysis by Flow Cytometry: Assay Validation and Characterization of 385 Consecutive Cases of Acute Myeloid Leukemia. Cancers, 17(7), 1155.
https://doi.org/10.3390/cancers17071155
